The Zyban stop smoking medication is essentially an antidepressant. In the U. S. , it is licensed for use in the treatment of depression, for seasonal affective disorder and for smoking cessation. The universal names used for the drug are Bupropion and Amfebutamone.
The brand name, when sold as an antidepressant in the United States, is Wellbutrin. In the UK, it is only licensed to be used in people who want to give up smoking, not for the treatment of depression or other disorders. It has no legal standing in other countries.
What does it do?
It is believed that nicotine increases the production of chemicals in the brain that make people ?feel good?. One of these chemicals is named dopamine. Only some scared cell receptors in the human body are affected by nicotine, causing them send out signals that cause dopamine release.
First, the Zyban stop smoking medicine prevents dopamine from breaking down so quickly in the system. It also contributes to the release of another ?feel good? chemical known as serotonin, so it may change and improve a person?s mood.
Second, it's been shown to stop cells from receiving the nicotine, at least partly. Folk have less wish to smoke, because the nicotine no longer produces the specified effect.
Some folk are anxious that they can gain weight if they give up smoking. Research has proven that Bupropion may forestall weight gain, at least on the near term. In time, skyrocketing activity helps many folks stop smoking and naturally forestalls weight gain.
What it does not do?
The Zyban stop smoking medicine only addresses the physical dependency or obsession that some of us have for nicotine. It does not address the habits or lifestyle issues that make people ?want? to smoke.
It isn't a sort of nicotine replacement therapy, like the patch or the gums. It will not completely stop a person?s wish to smoke. The bulk of the studies have shown that it reduces the desire to smoke by about 30%. Counseling and/or changing behavior is needed, if an individual actually wants to quit.
Compared to the health risks associated with smoking, the complications of the Zyban stop smoking drugs appear minor. Some folk experience dry mouth, which generally follows smoking a cigarette anyway. Nausea, sleeplessness, shaking, OTT sleeplessness, shaking, unnecessary sweating and ringing in the ears have also been reported.
The major risk that has been associated with Bupropion is fit. Wellbutrin was originally approved for the treatment of depression in 1984, but needed to be removed from the market in 1986, due to an increased likelihood of seizure.
The manufacturer, GlaxoSmithKline, was ready to show that the risk of seizure.
The manufacturer, GlaxoSmithKline, was related to the daily dosage. At 600mg/day the danger of fit At 100-300mg per day, the risk is about one tenth of a percent. So, the FDA allowed the drug to be re-released in 1989, with a maximum dosage of 450 mg/day.
When prescribed as the Zyban stop smoking drugs, the dosage is generally low, around 150mg/day, so the risk of seizure is minimal. There are many methods to stop smoking and some are more effective and safer than prescription drugs.
To learn more about your options, please visit Cigarest.inapill.com, a Stop Smoking drug resoruce site.